Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 study assessed the safety and effectiveness of Asoprisnil combined with estrogen in postmenopausal women; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amenorrhea
• Postmenopause

Drugs mentioned

• Asoprisnil (asoprisnil)
• Estrogen (Estrogen)

Snippet

Sponsor: Abbott | Conditions: Amenorrhea, Postmenopause | Phase 2 | Status: COMPLETED